What is Micro Medical Solutions?
Micro Medical Solutions operates at the intersection of advanced medical engineering and vascular health, specifically targeting the high-stakes domain of below-the-knee (BTK) interventions. By developing specialized tools designed to improve clinical outcomes for patients at risk of limb loss, the company addresses a significant gap in current surgical standards. Their market position is defined by a commitment to evidence-based innovation, serving as a critical partner for healthcare providers who require sophisticated, reliable instrumentation to navigate complex arterial blockages and improve long-term patient mobility.
How much funding has Micro Medical Solutions raised?
Micro Medical Solutions has raised a total of $2.8M across 3 funding rounds:
Debt
$150K
Debt
$161K
Private Equity
$2.5M
Debt (2020): $150K with participation from PPP
Debt (2021): $161K led by PPP
Private Equity (2025): $2.5M, investors not publicly disclosed
Key Investors in Micro Medical Solutions
Undisclosed Investor
An institutional partner providing strategic capital to support the advancement of critical limb ischemia intervention technologies.
PPP
Public-Private Partnership
What's next for Micro Medical Solutions?
With this major enterprise-level funding, Micro Medical Solutions is positioned to accelerate its research and development pipeline and expand its commercial footprint. The strategic deployment of this capital will likely focus on clinical trial expansion, regulatory milestones, and the scaling of manufacturing capabilities to meet the growing demand for advanced CLI treatment solutions. As the company transitions into this next phase of growth, the focus remains on establishing new benchmarks for limb salvage rates and solidifying its leadership in the vascular medical device sector.
See full Micro Medical Solutions company page
